Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced the opening of its new office, Promaxo BV, in Bruges, Belgium and the appointment of Pete Zaudtke as the Head of its European office.
“We are excited to expand our presence and enter Europe, with the opening of Promaxo BV, headquartered in Bruges, Belgium. From this launching pad, we look forward to initiating clinical studies, and developing regulatory as well as commercial pathways to provide European physicians and centers with access to our portable MRI system for point of care diagnostic biopsies and treatment of cancers, driving a shift to in-office diagnostic and treatment procedures,” stated Dr. Amit Vohra, Founder and CEO of Promaxo.
Pete Zaudtke said, “I am thrilled with the opportunity to lead Promaxo BV and the Company’s entry into Europe. This is a very exciting time for Promaxo, with its FDA approved single sided, AI enhanced imaging system for prostate cancer. We have a platform that represents the possibility for diagnostic biopsy and treatment in multiple indications paired with a strong commitment from Promaxo leadership to bring this technology to physicians and patients in Europe.”
Pete Zaudtke leverages over 15 years of international life sciences experience primarily focused on European market entry and launch preparations to lead Promaxo BV. Mr. Zaudtke currently leads a successful international life sciences advisory firm realizing record growth and has also previously served as CFO, VP of Operations of a US/Dutch oncology company he established.
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.
